U.S. Health Care Delivery Initiative
J-PAL North America’s U.S. Health Care Delivery Initiative (HCDI) supports randomized evaluations of strategies that aim to make health care delivery in the United States more efficient and more effective.
HCDI provides targeted funding for randomized impact evaluations that provide insights into which policies and programs are effective in improving health care delivery, and why. The initiative issues Requests for Proposals (RFPs) twice a year, in February and September, and proposals facing substantial time constraints are accepted off-cycle. J-PAL affiliates, J-PAL post-doctoral fellows, and HCDI members invited by J-PAL North America are eligible to apply for funding. Further details regarding HCDI’s RFPs can be found below.
HCDI directly supports U.S. federal, state, and local government health agencies and other health care organizations in designing and implementing randomized evaluations of innovative programs through the Health Care Delivery Innovation Competition.
Spurring New Research
HCDI connects policymakers, practitioners, and researchers to spur policy-relevant research on key health care issues. The initiative hosts large matchmaking conferences, convenes small gatherings of policymakers and researchers, and facilitates partnership development conversations.
HCDI’s Review Paper, written by Amy Finkelstein and Sarah Taubman, and published in Science explains the value of using randomized evaluations to improve U.S. health care delivery. The full-length version of the paper provides additional detail, including a discussion of specific strategies and opportunities to use randomized evaluations to evaluate health care programs.
We've also put together a quiz of individual narratives from Oregonians who participated in the Medicaid lottery, describing their experience of how Medicaid affected their health care, financial security, and health. These are all true stories, but only half are consistent with the prevailing experience of most people. Try your hand at identifying which one aligns with the evidence here.
HCDI builds the capacity of researchers, their staff, and collaborators at partner organizations to design and conduct high-quality randomized evaluations. As part of this effort, HCDI encourages best practices of research, including the registration of impact evaluations and the publication of data from funded evaluations.
J-PAL North America disseminates the results of funded evaluations to ensure that they reach decision makers in an accessible, salient format through policy briefs, online tools, reviews of the evidence, and evidence workshops. HCDI shares evidence with hospitals, health care service providers, and federal, state, and local policymakers in the United States as well as non-profit organizations, foundations, and social entrepreneurs. This outreach targets decision makers who choose policies, design programs, or decide how budgets are spent, in order to direct funds toward more evidence-based approaches and to scale up programs that work.
View a list of projects supported by HCDI.
J-PAL affiliate Amy Finkelstein (MIT)
For questions about HCDI, please email Jason Bauman, J-PAL North America Policy Manager.
The HCDI RFP solicits proposals from J-PAL affiliates, J-PAL post-docs, and HCDI members invited by J-PAL North America. To learn about HCDI funding opportunities for health agencies and health care organizations interested in designing and implementing randomized evaluations of innovative programs, please see the HCDI Innovation Competition.
HCDI RFP Winter 2017 Materials
- Application Form and Instructions – Seventh Round, Winter 2017
- Budget Template – Seventh Round, Winter 2017
- Travel/Project Development Grant Application, Winter 2017
Types of proposals:
- Full Research Projects (typically $150,000 to $400,000): research projects at a mature level of development with method of randomization, power calculations, etc.
- Pilot Studies (eligible for funding of $50,000 or less): studies with a clear research question where further testing and pilot testing could guide design and implementation; random assignment does not necessarily need to occur during a pilot study, but pilots must directly lead to a randomized evaluation.
- Travel/Project Development Grants (up to $5,000): exploratory work to develop a randomized evaluation related to the research themes of the RFP and open to graduate students of invited researchers.
Future rounds are expected to occur twice a year with deadlines in February and September. For time-sensitive research projects, J-PAL North America also accepts off-cycle proposals. We encourage pilot studies and travel/project development proposals facing time constraints to apply before the deadline. Decisions on these applications are typically made in about two weeks. The bar for approving full proposals off-cycle will be higher to ensure only the most time-senstive ones are submitted.
Who may apply?
For all proposals, the pool of eligible applicants includes J-PAL affiliates, J-PAL post-docs, and HCDI members invited by J-PAL North America. For travel/project development grants, the pool of eligible applicants is extended to include graduate students who have a J-PAL affiliate or invited researcher on their thesis committee at their host university. All proposals may include collaborators outside of this network, but the principle investigator (PI) must be an eligible applicant.
U.S. federal, state, and local government health agencies and other health care organizations can apply for technical support in developing randomized evaluations to study innovative programs and answer important policy questions, flexible funding to help design and test the feasibility of these evaluations, and partnerships with researchers in J-PAL’s network through the HCDI Innovation Competition.
Week of November 14, 2016 - RFP is issued
Friday, January 13, 2017 - Proposal Submission Deadline
Week of February 19, 2017 - Seventh Round Results Announced
Who will review applications?
Each proposal will be peer reviewed by one member of the Review Board and two researchers and/or policy experts not on the Review Board. The Review Board will meet to agree on final funding decisions.